Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             109 results found
no title author magazine year volume issue page(s) type
1 Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original article: S0169-409X(96)003304. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 99–112. 1 Wacher, Vincent J
 2001
 1-3 p. 89-102
14 p.
 article
2 Adenovirus-mediated gene transfer to liver 1 1 The article was originally published in Advanced Drug Delivery Reviews 17 (1995) 303–307. Wilson, James M.
 2001
 1-3 p. 205-209
5 p.
 article
3 Airway delivery of cationic lipid: DNA complexes for cystic fibrosis Cheng, S.H
 1998
 1-3 p. 173-184
12 p.
 article
4 A novel RU486 inducible system for the activation and repression of genes Chua, Steven S
 1998
 1-3 p. 23-31
9 p.
 article
5 Antibodies as delivery systems for diagnostic functions Khaw, Ban-An
 1999
 1-3 p. 63-80
18 p.
 article
6 Antibody delivery through the blood-brain barrier Bickel, Ulrich
 1995
 1-3 p. 53-72
20 p.
 article
7 Antisense drug delivery through the blood-brain barrier Boado, Ruben J.
 1995
 1-3 p. 73-107
35 p.
 article
8 Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium Gan, Liang-Shang L.
 1997
 1-3 p. 77-98
22 p.
 article
9 Approaches and agents for imaging the vascular system Bogdanov Jr., Alexei A
 1999
 1-3 p. 279-293
15 p.
 article
10 Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results Isner, Jeffrey M
 1998
 1-3 p. 185-197
13 p.
 article
11 Assaying extrachromosomal gene therapy vectors that carry replication/persistence elements Sclimenti, Christopher R
 1998
 1-3 p. 13-21
9 p.
 article
12 Avidin–biotin system for delivery of diagnostic agents Sakahara, Harumi
 1999
 1-3 p. 89-101
13 p.
 article
13 Bacteria-derived particles as adjuvants for non-replicating nasal vaccines Haneberg, Bjørn
 2001
 1-3 p. 143-147
5 p.
 article
14 Biochemical opening of the blood-brain barrier Black, Keith L.
 1995
 1-3 p. 37-52
16 p.
 article
15 Caco-2 monolayers in experimental and theoretical predictions of drug transport 1 PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84. 1 Artursson, Per
 2001
 1-3 p. 27-43
17 p.
 article
16 Chemistry and cellular aspects of cationic facial amphiphiles Walker, Suzanne
 1998
 1-3 p. 61-71
11 p.
 article
17 Chitosan as a novel nasal delivery system for vaccines Illum, L
 2001
 1-3 p. 81-96
16 p.
 article
18 Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection Wiebe, Leonard I.
 1999
 1-3 p. 63-80
18 p.
 article
19 Cystic fibrosis clinical trials Geddes, Duncan
 1998
 1-3 p. 205-217
13 p.
 article
20 Cytokines as adjuvants for the induction of mucosal immunity Boyaka, Prosper N.
 2001
 1-3 p. 71-79
9 p.
 article
21 Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound Tilcock, Colin
 1999
 1-3 p. 33-51
19 p.
 article
22 Delivery of contrast agents for positron emission tomography imaging by liposomes Oku, Naoto
 1999
 1-3 p. 53-61
9 p.
 article
23 Delivery of diagnostic agents: achievements and challenges Wolf, Gerald L
 1999
 1-3 p. 1-12
12 p.
 article
24 Delivery of diagnostic agents for gamma-imaging Arano, Yasushi
 1999
 1-3 p. 103-120
18 p.
 article
25 Delivery of diagnostic agents for magnetic resonance imaging Okuhata, Yoshitaka
 1999
 1-3 p. 121-137
17 p.
 article
26 Delivery of diagnostic agents in computed tomography Krause, Werner
 1999
 1-3 p. 159-173
15 p.
 article
27 Delivery of gamma-imaging agents by liposomes Phillips, William T.
 1999
 1-3 p. 13-32
20 p.
 article
28 Delivery of imaging agents into brain Abbott, N.Joan
 1999
 1-3 p. 253-277
25 p.
 article
29 Delivery of molecular and cellular medicine to solid tumors 1 PII of original article: S0169-409X(97)00027-6. The article was originally published in Advanced Drug Delivery Reviews 26 (1997) 71–90. 1 Jain, Rakesh K
 2001
 1-3 p. 149-168
20 p.
 article
30 Delivery of peptides and proteins through the blood–brain barrier Bickel, Ulrich
 2001
 1-3 p. 247-279
33 p.
 article
31 Delivery of radioligands for positron emission tomography (PET) in the central nervous system Tsukada, Hideo
 1999
 1-3 p. 175-188
14 p.
 article
32 Delivery systems for penetration enhancement of peptide and protein drugs: design considerations Kompella, Udaya Bhaskar
 2001
 1-3 p. 211-245
35 p.
 article
33 Development and optimization of anti-HIV nucleoside analogs and prodrugs: Tan, Xiaolei
 1999
 1-3 p. 117-151
35 p.
 article
34 Discrimination between drug candidates using models for evaluation of intestinal absorption Stewart, Barbra H.
 1997
 1-3 p. 27-45
19 p.
 article
35 Editorial 2001
 1-3 p. 1-2
2 p.
 article
36 Editorial Board 1995
 1-3 p. ii-iii
nvt p.
 article
37 Editorial Board 1997
 1-3 p. ii-
1 p.
 article
38 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Lipinski, Christopher A.
 1997
 1-3 p. 3-25
23 p.
 article
39 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1 PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 Lipinski, Christopher A
 2001
 1-3 p. 3-26
24 p.
 article
40 Factors affecting short-term and long-term stabilities of proteins Arakawa, Tsutomu
 2001
 1-3 p. 307-326
20 p.
 article
41 Forthcoming events 1995
 1-3 p. 179-180
2 p.
 article
42 Forthcoming issues 1995
 1-3 p. 177-
1 p.
 article
43 Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors Lehn, Pierre
 1998
 1-3 p. 5-11
7 p.
 article
44 Genetically engineered antibodies and their application to brain delivery Morrison, Sherie L.
 1995
 1-3 p. 147-175
29 p.
 article
45 Gene transfer with lipospermines and polyethylenimines Remy, Jean-Serge
 1998
 1-3 p. 85-95
11 p.
 article
46 Immobilized Artificial Membranes — screens for drug membrane interactions Yang, Cheng Y.
 1997
 1-3 p. 229-256
28 p.
 article
47 Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions Lundahl, Per
 1997
 1-3 p. 221-227
7 p.
 article
48 Immunostimulating complexes (ISCOMs) for nasal vaccination Hu, Ke-Fei
 2001
 1-3 p. 149-159
11 p.
 article
49 Improved uptake and retention of lipophilic prodrug to improve treatment of HIV Yatvin, Milton B
 1999
 1-3 p. 165-182
18 p.
 article
50 Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract 1 PII of original article: S0169-409X(96)00487-5. The article was originally published in Advanced Drug Delivery Reviews 25 (1997) 3–14. 1 Hörter, D
 2001
 1-3 p. 75-87
13 p.
 article
51 Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects Kabanov, Alexander V
 1998
 1-3 p. 49-60
12 p.
 article
52 Intranasal vaccination against plague, tetanus and diphtheria Alpar, H.O
 2001
 1-3 p. 173-201
29 p.
 article
53 Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system Sawchuk, Ronald J.
 1999
 1-3 p. 5-31
27 p.
 article
54 In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement LeCluyse, Edward L.
 1997
 1-3 p. 163-183
21 p.
 article
55 In vitro models to predict blood-brain barrier permeability Eddy, Evangeline Priya
 1997
 1-3 p. 185-198
14 p.
 article
56 In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption Burton, Philip S.
 1997
 1-3 p. 143-156
14 p.
 article
57 In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists Ellens, Harma
 1997
 1-3 p. 99-109
11 p.
 article
58 Involvement of multiple transporters in the oral absorption of nucleoside analogues Balimane, Praveen V.
 1999
 1-3 p. 183-209
27 p.
 article
59 Key issues in non-viral gene delivery 1 PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19. 1 Pouton, Colin W
 2001
 1-3 p. 187-203
17 p.
 article
60 Liposomes for scintigraphic detection of infection and inflammation Laverman, Peter
 1999
 1-3 p. 225-235
11 p.
 article
61 Manipulating the immune system: humoral versus cell-mediated immunity McNeela, Edel A.
 2001
 1-3 p. 43-54
12 p.
 article
62 Manufacturing and quality control of plasmid-based gene expression systems Durland, Ross H
 1998
 1-3 p. 33-48
16 p.
 article
63 Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus Schaner, Marci E
 1999
 1-3 p. 51-62
12 p.
 article
64 Microparticles for intranasal immunization Vajdy, Michael
 2001
 1-3 p. 127-141
15 p.
 article
65 Multiple-model evaluation of absorption of a tachykinin receptor antagonist Chan, O.Helen
 1997
 1-3 p. 121-131
11 p.
 article
66 Nasal delivery of epitope based vaccines Olszewska, Wieslawa
 2001
 1-3 p. 161-171
11 p.
 article
67 Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future 2001
 1-3 p. 1-3
3 p.
 article
68 Nasal vaccination using live bacterial vectors Mielcarek, Nathalie
 2001
 1-3 p. 55-69
15 p.
 article
69 Nasal vaccines Davis, S.S.
 2001
 1-3 p. 21-42
22 p.
 article
70 Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal tissue Baird, Alan W.
 1997
 1-3 p. 111-120
10 p.
 article
71 Oral absorption of β-lactams by intestinal peptide transport proteins Dantzig, Anne H.
 1997
 1-3 p. 63-76
14 p.
 article
72 Oral absorption of the HIV protease inhibitors: a current update Williams, Gregory C.
 1999
 1-3 p. 211-238
28 p.
 article
73 P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs Aungst, Bruce J.
 1999
 1-3 p. 105-116
12 p.
 article
74 Pharmacokinetic considerations in somatic gene therapy Ledley, Fred D
 1998
 1-3 p. 133-150
18 p.
 article
75 Plasmid delivery to muscle: Mumper, Russell J
 1998
 1-3 p. 151-172
22 p.
 article
76 Polylysine-based transfection systems utilizing receptor-mediated delivery Zauner, Wolfgang
 1998
 1-3 p. 97-113
17 p.
 article
77 Polymeric lamellar substrate particles for intranasal vaccination Jabbal-Gill, Inderjit
 2001
 1-3 p. 97-111
15 p.
 article
78 Polymeric micelles as carriers of diagnostic agents Trubetskoy, Vladimir S.
 1999
 1-3 p. 81-88
8 p.
 article
79 Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy Hung, Mien-Chie
 1998
 1-3 p. 219-227
9 p.
 article
80 Pre-clinical trials using hepatic gene delivery Grove, Robert I
 1998
 1-3 p. 199-204
6 p.
 article
81 Preface Rolland, Alain
 1998
 1-3 p. 1-3
3 p.
 article
82 Preface Lee, Yong Hee
 1999
 1-3 p. 1-3
3 p.
 article
83 Preface Smith, Philip
 1997
 1-3 p. 1-
1 p.
 article
84 Preface: Overview of brain drug delivery Pardridge, William M.
 1995
 1-3 p. 1-3
3 p.
 article
85 Radionuclide imaging of cardiac pathology: a mechanistic perspective Bhatnagar, Anish
 1999
 1-3 p. 213-223
11 p.
 article
86 Recent advances in liposome technologies and their applications for systemic gene delivery Chonn, Arcadio
 1998
 1-3 p. 73-83
11 p.
 article
87 Responsive polymeric delivery systems Kost, Joseph
 2001
 1-3 p. 125-148
24 p.
 article
88 Review of intranasal influenza vaccine Glueck, Reinhard
 2001
 1-3 p. 203-211
9 p.
 article
89 Role of dosage regimen in controlling indirect pharmacodynamic responses 1 PII of the original article: S0169-409X(98)—30-1. The article was originally published in Advanced Drug Delivery Reviews 33 (1998) 221–233. 1 Gobburu, Jogarao V.S.
 2001
 1-3 p. 45-57
13 p.
 article
90 Role of pharmacokinetics in the discovery and development of indinavir Lin, Jiunn H.
 1999
 1-3 p. 33-49
17 p.
 article
91 Selection of development candidates based on in vitro permeability measurements Lee, Chao-Pin
 1997
 1-3 p. 47-62
16 p.
 article
92 Simulation models to predict oral drug absorption from in vitro data Grass, George M.
 1997
 1-3 p. 199-219
21 p.
 article
93 SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Maeda, Hiroshi
 2001
 1-3 p. 169-185
17 p.
 article
94 Studies of macromolecular prodrugs of zidovudine Giammona, G.
 1999
 1-3 p. 153-164
12 p.
 article
95 Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography Moghimi, S.M.
 1999
 1-3 p. 295-312
18 p.
 article
96 Synthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery von Hoegen, Paul
 2001
 1-3 p. 113-125
13 p.
 article
97 Synthetic peptide-based DNA complexes for nonviral gene delivery Smith, Louis C
 1998
 1-3 p. 115-131
17 p.
 article
98 Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging Klibanov, Alexander L.
 1999
 1-3 p. 139-157
19 p.
 article
99 Targeted imaging of infection Babich, John W.
 1999
 1-3 p. 237-252
16 p.
 article
100 The effect of chemical modifications on octanol/water partition (log D) and permeabilities across Caco-2 monolayers Rubas, Werner
 1997
 1-3 p. 157-162
6 p.
 article
101 The nose and paranasal sinuses physiology and anatomy Jones, Nick
 2001
 1-3 p. 5-19
15 p.
 article
102 The potential use of receptor-mediated endocytosis for oral drug delivery 1 PII of original article: S0169_409X(96)00334-1. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 83–97. 1 Russell-Jones, G.J
 2001
 1-3 p. 59-73
15 p.
 article
103 The role of electroosmotic flow in transdermal iontophoresis Pikal, Michael J.
 2001
 1-3 p. 281-305
25 p.
 article
104 The role of γ-scintigraphy in oral drug delivery Wilding, I.R
 2001
 1-3 p. 103-124
22 p.
 article
105 The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists Samanen, James M.
 1997
 1-3 p. 133-142
10 p.
 article
106 Transport, metabolism and elimination mechanisms of anti-HIV agents Li, Xiaoling
 1999
 1-3 p. 81-103
23 p.
 article
107 Transport of small molecules through the blood-brain barrier: biology and methodology Pardridge, William M.
 1995
 1-3 p. 5-36
32 p.
 article
108 Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis Cutler, Cathy S.
 1999
 1-3 p. 189-211
23 p.
 article
109 Vector-mediated peptide drug delivery to the brain Pardridge, William M.
 1995
 1-3 p. 109-146
38 p.
 article
                             109 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands